查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519786

2024-2032 年按產品類型、應用、最終用戶和地區分類的皮下注射針市場報告

Hypodermic Needles Market Report by Product Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球皮下注射針頭市場規模達29億美元。由於慢性病發病率上升、疫苗和注射藥物需求不斷增加、提高患者舒適度和安全性的突破性技術以及全球（尤其是新興經濟體）戰略性醫療基礎設施的擴張，皮下注射針頭市場正在經歷顯著成長。

皮下注射針市場分析：

主要市場促進因素：皮下注射針頭市場的成長主要受到以下因素的推動：需要注射藥物的慢性病盛行率不斷上升、對疫苗和治療藥物的需求不斷增加、提高針頭安全性和患者舒適度的技術進步以及全球醫療保健基礎設施的擴大。

主要市場趨勢：皮下注射針頭市場趨勢包括採用安全設計的針頭以最大程度地減少針刺傷害、越來越傾向於使用較小規格的針頭以減少患者不適，以及用於無痛給藥的無針注射系統的出現。

地理趨勢：由於其發達的醫療保健系統、嚴格的安全法規以及最新針頭技術的高採用率，北美在皮下注射針頭市場中佔有最大佔有率。此外，慢性病數量和醫療保健支出的增加正在推動該地區在全球醫藥市場中佔據領先地位。

競爭格局：皮下注射針頭行業的一些主要市場參與者包括 B. Braun Melsungen AG、Becton Dickinson and Company、Cardinal Health Inc.、Connecticut Hypodermics Inc.、EXELINT International Co、Hi-Tech Syringes、McKesson Corporation、Medline Industries LP 、Nipro Corporation、Retractable Technologies Inc.、Smiths Medical Inc. (ICU Medical Inc.)、Terumo Corporation 等。

挑戰與機會：皮下注射針頭市場面臨挑戰，例如對針頭處置和環境影響、醫護人員針刺傷害以及嚴格的監管要求的擔憂日益增加。然而，在創新針頭技術的開發、新興市場的擴張以及旨在解決未滿足的需求和改善患者護理的研發合作方面存在機會。

皮下注射針市場趨勢：

持續的醫療進步推動需求：

新的和先進的醫療程序以及醫療保健的不斷普及增加了皮下注射針頭的市場需求。例如，美國疾病管制與預防中心 (CDC) 表示，美國每年約有 160 億次注射，這顯示了針頭在現代醫學中的作用和重要性。除此之外，疫苗接種計劃、胰島素治療和其他醫療干預措施的增加增加了對皮下注射針的需求，這些注射針是這些醫療設備在拯救人們生命方面不可或缺的一部分，從而推動了市場成長。除了全球人口老化之外，慢性疾病增加了對胰島素等注射藥物的需求，從而不斷增加對注射器和針頭的需求。

慢性病盛行率上升：

世界各地的糖尿病和癌症等慢性疾病的數量每天都在增加。根據世界衛生組織 (WHO) 的數據，非傳染性疾病是世界上最主要的死亡原因，約佔所有死亡人數的 60%。因此，需要持續供應皮下注射或靜脈注射針頭來注射胰島素和化療藥物等藥物。此外，由於對慢性病患者管理的需求不斷成長，產量不斷增加，皮下注射針頭市場正在經歷顯著成長。此外，生物技術的創新突破導致更多的注射藥物生產，從而增加了對皮下注射針頭的需求。

政府疾病預防措施：

許多國家正在將預算分配給疾病預防和控制措施，例如大規模免疫和旨在預防愛滋病毒/愛滋病的措施。例如，聯合國永續發展目標針對所有年齡層的人，以改善健康和保健。作為這些措施的一部分，正在部署以皮下注射針為核心的疫苗接種計劃，以滿足對這些物品的需求。隨著各國政府越來越關注公共衛生議程並分配資源來對抗傳染病，由於在改善醫療服務的獲取和結果方面的共同努力，無針注射器市場將經歷長期永續成長。例如，世界衛生組織 (WHO) 表示，2020 年，全球有 1.16 億嬰兒接種了三劑白喉-破傷風-百日咳 (DTP) 疫苗，證明了疫苗接種的巨大潛力。此外，美國的行動也促成了同樣的原因。

皮下注射針市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品類型、應用和最終用戶對市場進行了分類。

按產品類型分類：

安全皮下注射針

非安全皮下注射針頭

安全皮下注射針佔據大部分市場佔有率

該報告根據產品類型對市場進行了詳細的細分和分析。這包括安全皮下注射針頭和非安全皮下注射針頭。根據該報告，安全皮下注射針頭佔最大佔有率。

安全皮下注射針可避免醫護人員和病患的針刺傷和感染危險。據美國職業安全與健康管理局 (OSHA) 稱，全球每年有數百萬醫護人員遭受針刺傷。這是一個重大問題，主要是因為感染血液傳染疾病的高風險。職業安全與健康管理局 (OSHA) 表示，採用可伸縮/防護針等安全工程設備有助於擴大這些傷害之間的差距。例如，OSHA 估計，在美國，使用安全工程設備每年可以預防約 3.85 億次針刺傷害。雖然強制執行更安全工作環境的法規正在採用安全皮下注射針頭的使用，但這種情況可能會增加，這將成為該產品後續市場佔有率的關鍵因素。

按應用分類：

藥物輸送

疫苗接種

血液樣本採集

報告還提供了基於應用程式的詳細市場細分和分析。這包括藥物輸送、疫苗接種和血液樣本採集。

在藥物傳遞方面，慢性病的增加增加了對適當和準確用藥的需求，這直接促進了皮下注射針頭的市場需求。生物技術和製藥的進步以及注射劑的發明增加了這種高水準的要求。由於全球大力推動傳染病的疫苗接種，全球疫苗計畫中針頭的使用量增加。 COVID-19 大流行凸顯了疫苗接種計畫在公共衛生中的重要性，促使皮下注射針頭的需求增加。此外，用於診斷目的的血液採樣仍然是衛生機構中最重要的血液採集方法，確保對皮下注射針頭的持續需求。這些應用確保了皮下注射針市場的持續發展。

按最終用戶分類：

醫院和診所

門診手術中心

糖尿病患者

家庭實踐

精神科

其他

醫院和診所是領先的細分市場

該報告提供了基於最終用戶的詳細市場細分和分析。這包括醫院和診所、門診手術中心、糖尿病患者、家庭診所、精神科等。報告稱，醫院和診所是最大的部分。

醫院和診所推動皮下注射針頭市場的成長，在提供衛生服務方面發揮關鍵作用。根據美國醫院協會 (AHA) 統計，到 2021 年，美國至少有 6000 家獲得許可的醫院在營運，多年來為數百萬患者提供服務。皮下注射針頭是不可或缺的醫療設備，在醫院和診所進行的眾多治療和程序中使用，例如疫苗接種、注射、抽血和診斷。由於人口老化和慢性病患者數量的增加，醫院和診所對皮下注射針頭的消耗導致這些機構大量獲得皮下注射針頭。此外，政府衛生機構制定的嚴格感染控制協議可確保醫院和診所的品質並防止疾病傳播，從而確保病人安全和良好的醫療效果。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的皮下注射針市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是皮下注射針最大的區域市場。

北美仍然是皮下注射針頭市場的主導力量，因為該地區擁有良好的醫療基礎設施，醫療保健支出位居全國最高，對皮下注射針頭等醫療器材產生了顯著的需求。例如，醫療保險和醫療補助服務中心（CMS）報告稱，2020年美國的醫療保健支出達到4.1兆美元，這意味著美國在醫療服務和產品上投入了大量資金。此外，美國食品藥物管理局 (FDA) 等機構制定了嚴格的監管標準，以確保皮下注射針頭的有效性、可靠性和可用性，這對於醫療保健提供者和患者至關重要。此外，該地區專注於創新並採用最新醫療保健實踐的醫療設備，從而促進了皮下注射針頭的使用，從而使北美成為全球皮下注射針頭市場的市場領導者。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。皮下注射針頭行業的一些主要市場參與者包括 B. Braun Melsungen AG、Becton Dickinson and Company、Cardinal Health Inc.、Connecticut Hypodermics Inc.、EXELINT International Co.、Hi-Tech Syringes、McKesson Corporation、Medline Industries LP、 Nipro Corporation、Retractable Technologies Inc.、Smiths Medical Inc. (ICU Medical Inc.) 和Terumo Corporation。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

皮下注射針頭市場的主要參與者正在尋找新的方法來提高注射過程的安全性、準確性和舒適性。例如，BD（Becton，Dickinson and Company）是一家領先的製造商，它突出了大多數現代針技術。 BD 2021 會計年度的收入為 170.9 億美元，這表明了其在市場中的排名。另一個主要參與者 Terumo Corporation 提倡使用更鋒利的醫療安全設備，如 SurGuard 3 安全針所示。 Terumo 在截至 2021 年 3 月 31 日的會計年度中的變動相當於 7,149 億日元，這表明了其市場影響。優先考慮新針產品的研究和開發創新的市場主要參與者是當今市場成長的最強大驅動力。

皮下注射針市場新聞：

2020 年 12 月，Becton, Dickinson and Company (BD) 宣布計劃在四年內投資約 12 億美元，以擴大和升級預充式注射器 (PFS) 和先進藥物輸送的製造能力和技術。這項投資包括在歐洲增加一個新的製造工廠。

本報告回答的關鍵問題：

  • 迄今為止，全球皮下注射針頭市場表現如何，未來幾年將如何表現？
  • 全球皮下注射針市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球皮下注射針頭市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的皮下注射針頭市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 皮下注射針頭市場中最具吸引力的產品類型是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 皮下注射針市場最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 皮下注射針頭市場中哪一個對最終用戶最具吸引力？
  • 市場競爭結構如何？
  • 誰是全球皮下注射針市場的主要參與者/公司？

本報告回答的關鍵問題：

  • 迄今為止，全球皮下注射針頭市場表現如何，未來幾年將如何表現？
  • 全球皮下注射針市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球皮下注射針頭市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的皮下注射針頭市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 皮下注射針頭市場中最具吸引力的產品類型是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 皮下注射針市場最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 皮下注射針頭市場中哪一個對最終用戶最具吸引力？
  • 市場競爭結構如何？
  • 誰是全球皮下注射針市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球皮下注射針市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 安全皮下注射針
    • 市場走向
    • 市場預測
  • 非安全皮下注射針頭
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 藥物輸送
    • 市場走向
    • 市場預測
  • 疫苗接種
    • 市場走向
    • 市場預測
  • 血液樣本採集
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 糖尿病患者
    • 市場走向
    • 市場預測
  • 家庭實踐
    • 市場走向
    • 市場預測
  • 精神科
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • B. Braun Melsungen AG
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Connecticut Hypodermics Inc.
    • EXELINT International Co.
    • Hi-Tech Syringes
    • McKesson Corporation
    • Medline Industries LP
    • Nipro Corporation
    • Retractable Technologies Inc.
    • Smiths Medical Inc. (ICU Medical Inc.)
    • Terumo Corporation
Product Code: SR112024A5092

The global hypodermic needles market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. The hypodermic needles market is experiencing significant growth driven by increasing incidence of chronic diseases, rising demand for vaccinations and injectable medicines, needle breakthrough technologies that enhance comfort and safety for patients, and the expansion strategic healthcare infrastructure all over the world especially in the emerging economies.

Hypodermic Needles Market Analysis:

Major Market Drivers: The hypodermic needles market growth is significantly driven by the rising prevalence of chronic diseases requiring injectable medications, increasing demand for vaccines and therapeutic drugs, technological advancements enhancing needle safety and patient comfort, and expanding healthcare infrastructure globally.

Key Market Trends: The hypodermic needles market trends include the adoption of safety-engineered needles to minimize needlestick injuries, the growing preference for smaller gauge needles for reduced patient discomfort, and the emergence of needle-free injection systems for painless drug delivery.

Geographical Trends: North America has the largest share of the hypodermic needles market due to its a developed healthcare system, stringent safety regulations and a high adoption rate of the latest needle technologies. Moreover, the increasing numbers of chronic diseases and healthcare expenditure are driving the region to take the lead in the global pharmaceutical market.

Competitive Landscape: Some of the major market players in the hypodermic needles industry include B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.), Terumo Corporation, among many others.

Challenges and Opportunities: The hypodermic needles market faces challenges sich as rising concerns regarding needle disposal and environmental impact, needlestick injuries among healthcare workers, and stringent regulatory requirements. However, opportunities exist in the development of innovative needle technologies, expansion into emerging markets, and collaborations for research and development aimed at addressing unmet needs and improving patient care.

Hypodermic Needles Market Trends:

Ongoing Medical Advancements Driving Demand:

New and advanced medical procedures and the rising spread of health care has augmented the hypodermic needles market demand. For instance, the Centers for Disease Control and Prevention (CDC) stated that there are approximately 16 billion injections performed yearly in the United States indicating the role and importance of needles in modern medicine. Apart from this, the increase of vaccination programs, insulin therapy and other medical interventions has escalated the demand for hypodermic needles which show an integral part of these medical equipment in saving people's life, thus propelling the market growth. In addition to aging populations worldwide, chronic diseases have heightened the need of injecting medications such as insulin which constantly increase demand of syringes and needles.

Rising Prevalence of Chronic Diseases:

The number of chronic diseases from all over the world like diabetes and cancer is expanding every day. As per the World Health Organization (WHO), non-communicable diseases are the leading the cause of death in the world and these diseases are responsible for about 60% of all deaths. As a result, a constant supply of hypodermic or intravenous needles is required for injecting medications such as insulin and chemo drugs. Furthermore, with the increasing amount of production due to a growing need for chronically ill patient management, the hypodermic needles market is experiencing significant growth. Furthermore, the innovative breakthroughs in biotechnology result in more injectable medication manufacturing, escalating the demand for hypodermic needles escalates.

Government Initiatives for Disease Prevention:

Many countries are allocating their budgets to disease prevention and control measures, such as mass immunization and measures aimed at preventing HIV/AIDS. For instance, the UNSDGs that targets all ages to improve health and wellness. As part of these initiatives, vaccination programs with hypodermic needles as the central element are being deployed, meeting the need for these items. With governments increasingly focusing on the public health agenda and allocating resources to combat infectious diseases, the needle-free injector market is set to experience a long-term sustainable growth due to such concerted efforts at improving the access to and the outcome of care. For instance, during the year of 2020, the World Health Organization (WHO) indicated that 116 million infants across the globe received three doses of the diphtheria-tetanus-pertussis (DTP) vaccine demonstrating the significant potential of vaccination. Additionally, actions as the USA have contributed to the same cause.

Hypodermic Needles Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, application, and end user.

Breakup by Product Type:

Safety Hypodermic Needles

Non-Safety Hypodermic Needles

Safety hypodermic needles accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes safety hypodermic needles and non-safety hypodermic needles. According to the report, safety hypodermic needles represented the largest segment.

Safety hypodermic needles can avoid needlestick injury and infection hazards among healthcare staff and patients. As stated by the Occupational Safety and Health Administration (OSHA), millions of healthcare workers around the world are affected by needlestick injuries every year. It is a significant issue mainly because of high-risk of contracting bloodborne diseases. The Occupational Safety and Health Administration (OSHA) indicated that implementing safety-engineered devices like retractable/shielded needles can help to widen the gap between these injuries. For instance, OSHA estimates that about 385 million needlestick injuries can be maybe prevented in the United States every year using safety engineered devices. While regulations enforcing safer working environment are adopting the use of safety hypodermic needles, this is likely going to increase, which will be a key factor in the subsequent market share for that product.

Breakup by Application:

Drug Delivery

Vaccination

Blood Specimen Collection

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes drug delivery, vaccination, and blood specimen collection.

In drug delivery, the rise of chronic diseases has escalated the need to have proper and accurate administration of medication which is directly contributing to hypodermic needles market demand. The progress of biotechnology and pharmaceuticals, and the invention of injectable types add to this high level of requests. There has been a rise in needle usage with vaccine programs worldwide mostly, due to the global push for inoculation against infectious diseases. The COVID-19 pandemic has heightened the significance of vaccination projects in public health prompting an increase of demand for hypodermic needles. Furthermore, blood sampling for diagnostic purposes is still the most important blood collection method in health facilities ensuring the consistent demand for hypodermic needles. These applications ensure the continued development of the hypodermic needles market.

Breakup by End User:

Hospitals and Clinics

Ambulatory Surgical Centers

Diabetic Patients

Family Practices

Psychiatrics

Others

Hospitals and clinics represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, ambulatory surgical centers, diabetic patients, family practices, psychiatrics, and others. According to the report, hospitals and clinics represented the largest segment.

Hospitals and clinics propel the hypodermic needles market growth, having a key role in provision of health services. According to the American Hospital Association (AHA), the country had at least 6000 licensed hospitals operating in 2021, serving millions of patients over the years. Hypodermic needles in their turn are indispensable medical equipment that is used throughout numerous treatments and procedures carried out in hospitals and clinics, such as vaccinations, injections, blood drawings and diagnostics. As a result of aging population and the growing number of people with chronic diseases, the consumption of hypodermic needles in hospitals and clinics leads to the fact that these establishments are gaining hypodermic needles in large amounts. In addition, stringent infection control protocols established by government health agencies ensure quality and prevent the spreading of diseases in hospitals and in the clinics, environment guaranteeing patient safety and excellent healthcare results.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest hypodermic needles market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hypodermic needles.

North America remains the force of the hypodermic needles market as the region features a good healthcare infrastructure and the healthcare expenditure among the highest in the country generates a notable demand for medical devices, such as hypodermic needles. For instance, the Centers for Medicare & Medicaid Services (CMS), reported that healthcare expenditure in the United States reached $4.1 trillion in 2020, meaning that the nation has invested vast amount of money in health services and products. Besides, agencies like the Food and Drug Administration (FDA) impose stringent regulatory standards that ensure the effectiveness, reliability, and usability of hypodermic needles which are essential for healthcare providers and patients. Also, the region concentrates on medical devices that are both innovative and uses the latest healthcare practices which in turn boosts the use of hypodermic needles, thus placing North America as a market leader in the global hypodermic needles market.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the hypodermic needles industry include B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The key players in the hypodermic needles market are finding new ways to improve the safety, accuracy, and comfort during the injection. For instance, BD (Becton, Dickinson and Company), which is a leading manufacturer, and which highlighted most of the modern needle technologies. BD finishes FY 2021 with revenue of $17.09 billion thus indicating how it ranks in the market. The Terumo Corporation, another major player, advocates for sharper medical safety devices as shown by its SurGuard 3 safety needle. Terumo's movements during the fiscal year ended March 31, 2021, equaled to ¥714.9 billion, which shows its market impact. Market main actors whose priority is innovation in research and the development of new needle products being the most powerful drivers of the market growth in the present era.

Hypodermic Needles Market News:

In December 2020, Becton, Dickinson and Company (BD) announced plans to invest approximately $1.2 billion over a four-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery. This investment includes the addition of a new manufacturing facility in Europe.

Key Questions Answered in This Report:

  • How has the global hypodermic needles market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global hypodermic needles market?
  • What is the impact of each driver, restraint, and opportunity on the global hypodermic needles market?
  • What are the key regional markets?
  • Which countries represent the most attractive hypodermic needles market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the hypodermic needles market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the hypodermic needles market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the hypodermic needles market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global hypodermic needles market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hypodermic Needles Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Safety Hypodermic Needles
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Safety Hypodermic Needles
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Delivery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Vaccination
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Blood Specimen Collection
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diabetic Patients
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Family Practices
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Psychiatrics
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 B. Braun Melsungen AG
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cardinal Health Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Connecticut Hypodermics Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 EXELINT International Co.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Hi-Tech Syringes
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 McKesson Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medline Industries LP
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Nipro Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Retractable Technologies Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Smiths Medical Inc. (ICU Medical Inc.)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 SWOT Analysis
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Hypodermic Needles Market: Major Drivers and Challenges
  • Figure 2: Global: Hypodermic Needles Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Hypodermic Needles Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Hypodermic Needles Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Hypodermic Needles Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Hypodermic Needles Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Hypodermic Needles Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Hypodermic Needles (Safety Hypodermic Needles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Hypodermic Needles (Safety Hypodermic Needles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Hypodermic Needles (Non-Safety Hypodermic Needles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Hypodermic Needles (Non-Safety Hypodermic Needles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Hypodermic Needles (Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Hypodermic Needles (Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Hypodermic Needles (Vaccination) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Hypodermic Needles (Vaccination) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Hypodermic Needles (Blood Specimen Collection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Hypodermic Needles (Blood Specimen Collection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Hypodermic Needles (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Hypodermic Needles (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Hypodermic Needles (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Hypodermic Needles (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Hypodermic Needles (Diabetic Patients) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Hypodermic Needles (Diabetic Patients) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Hypodermic Needles (Family Practices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Hypodermic Needles (Family Practices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Hypodermic Needles (Psychiatrics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Hypodermic Needles (Psychiatrics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Hypodermic Needles (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Hypodermic Needles (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Hypodermic Needles Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Hypodermic Needles Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Hypodermic Needles Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Hypodermic Needles Industry: SWOT Analysis
  • Figure 80: Global: Hypodermic Needles Industry: Value Chain Analysis
  • Figure 81: Global: Hypodermic Needles Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hypodermic Needles Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Hypodermic Needles Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Hypodermic Needles Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Hypodermic Needles Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Hypodermic Needles Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Hypodermic Needles Market: Competitive Structure
  • Table 7: Global: Hypodermic Needles Market: Key Players